Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN94288 - Provider product page
- Provider
- antibodies-online
- Proper citation
- Antibodies-Online Cat#ABIN94288, RRID:AB_10770436
- Product name
- anti-Keratin 19 (KRT19) antibody
- Antibody type
- Monoclonal
- Antigen
- Mammary organoids.
- Description
- Purified from rabbit serum by protein-A afinity chromatography
- Reactivity
- Human
- Host
- Mouse
- Isotype
- IgG
- Antibody clone number
- BA-17
- Vial size
- 0.1 mg
- Concentration
- 1 mg/ml
- Storage
- 4°C
Submitted references Generation of fluorescently labeled cell lines, C3A hepatoma cells, and human adult skin fibroblasts to study coculture models.
The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.
A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins.
Samluk A, Zakrzewska KE, Pluta KD
Artificial organs 2013 Jul;37(7):E123-30
Artificial organs 2013 Jul;37(7):E123-30
The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
Lewis BC, Klimstra DS, Varmus HE
Genes & development 2003 Dec 15;17(24):3127-38
Genes & development 2003 Dec 15;17(24):3127-38
Patterns of expression of keratin 19 as detected with monoclonal antibodies in human breast tissues and tumours.
Bartek J, Taylor-Papadimitriou J, Miller N, Millis R
International journal of cancer. Journal international du cancer 1985 Sep 15;36(3):299-306
International journal of cancer. Journal international du cancer 1985 Sep 15;36(3):299-306
A subclass of luminal epithelial cells in the human mammary gland, defined by antibodies to cytokeratins.
Bartek J, Durban EM, Hallowes RC, Taylor-Papadimitriou J
Journal of cell science 1985 Apr;75:17-33
Journal of cell science 1985 Apr;75:17-33
No comments: Submit comment
No validations: Submit validation data